BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38574015)

  • 1. The role of Lesotho community pharmacists in preventing and controlling cardiovascular diseases: The perceived facilitators and barriers.
    Motlohi NF; Mensah KB; Padayachee N; Petrus R; Bangalee V
    PLoS One; 2024; 19(4):e0301525. PubMed ID: 38574015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
    Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian community pharmacists' awareness and practice in supporting secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2013 Dec; 35(6):1218-28. PubMed ID: 24057435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design.
    Buss VH; Shield A; Kosari S; Peterson GM; Naunton M
    Int J Clin Pharm; 2020 Dec; 42(6):1385-1395. PubMed ID: 32803556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study.
    Salgado TM; Moles R; Benrimoj SI; Fernandez-Llimos F
    Int J Clin Pharm; 2012 Aug; 34(4):569-78. PubMed ID: 22538466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health consumer engagement in developing novel preventive health community pharmacy roles in cardiovascular disease in Saudi Arabia: A qualitative analysis.
    Almansour HA; Aloudah NM; Alhawassi TM; Chaar B; Krass I; Saini B
    Saudi Pharm J; 2020 May; 28(5):529-537. PubMed ID: 32435133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives of community pharmacists in Pakistan about practice change and implementation of extended pharmacy services: a mixed method study.
    Hashmi F; Hassali MA; Saleem F; Saeed H; Islam M; Malik UR; Atif N; Babar ZU
    Int J Clin Pharm; 2021 Aug; 43(4):1090-1100. PubMed ID: 33411180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacists' perspective of medication adherence support in Ethiopian hospital settings: a qualitative study.
    Tegegn HG; Wark S; Tursan d'Espaignet E; Spark MJ
    Int J Pharm Pract; 2023 Dec; 31(6):617-624. PubMed ID: 37721550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-perceived barriers and facilitators to the implementation of a medication review in primary care: a qualitative thematic analysis.
    Uhl MC; Muth C; Gerlach FM; Schoch GG; Müller BS
    BMC Fam Pract; 2018 Jan; 19(1):3. PubMed ID: 29304725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study.
    Marquis J; Schneider MP; Spencer B; Bugnon O; Du Pasquier S
    Int J Clin Pharm; 2014 Oct; 36(5):1014-22. PubMed ID: 25139136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the role of community pharmacists in the prevention and control of cardiovascular diseases: the perceptions of patients.
    Motlohi NF; Wiafe E; Mensah KB; Padayachee N; Petrus R; Bangalee V
    Syst Rev; 2023 Sep; 12(1):160. PubMed ID: 37705090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative study of community pharmacists' opinions on the provision of osteoporosis disease state management services in Malaysia.
    Nik J; Lai PS; Ng CJ; Emmerton L
    BMC Health Serv Res; 2016 Aug; 16(1):448. PubMed ID: 27577560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enablers and challenges to pharmacy practice change in Kuwait hospitals: a qualitative exploration of pharmacists' perceptions.
    Katoue MG
    J Eval Clin Pract; 2021 Apr; 27(2):272-279. PubMed ID: 32929812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight management in community pharmacy: what do the experts think?
    Um IS; Armour C; Krass I; Gill T; Chaar BB
    Int J Clin Pharm; 2013 Jun; 35(3):447-54. PubMed ID: 23456174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacists' perceptions on providing fall prevention services: a mixed-methods study.
    Gemmeke M; Koster ES; Rodijk EA; Taxis K; Bouvy ML
    Int J Clin Pharm; 2021 Dec; 43(6):1533-1545. PubMed ID: 34121152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists' perspectives.
    Kennelty KA; Chewning B; Wise M; Kind A; Roberts T; Kreling D
    Res Social Adm Pharm; 2015; 11(4):517-30. PubMed ID: 25586885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and facilitators for providing self-care advice in community pharmacies: a qualitative study.
    Lelie-van der Zande R; Koster ES; Teichert M; Bouvy ML
    Int J Clin Pharm; 2023 Jun; 45(3):758-768. PubMed ID: 37029859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' experiences and views on providing screening services: An international comparison.
    Alzubaidi H; Namara KM; Saidawi W; Hasan S; Krass I
    Res Social Adm Pharm; 2020 Nov; 16(11):1558-1568. PubMed ID: 32830071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supporting respiratory patients in primary care: a qualitative insight from independent community pharmacists in London.
    Hesso I; Kayyali R; Nabhani-Gebara S
    BMC Health Serv Res; 2019 Jan; 19(1):5. PubMed ID: 30611264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.